Shunichiro Onishi
Narita, 2868686, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Increased autoantibodies against incretin indicate poor prognosis in patients with diabetes.
Journal: Scientific reports
Published: May 14, 2025
Iron overload may be critical for liver dysfunction in anorexia nervosa, and the role of haematocrit-adjusted albumin in assessing nutritional status: a case report.
Journal: BMC pediatrics
Published: February 12, 2023
Association of high proprotein convertase subtilisin/kexin type 9 antibody level with poor prognosis in patients with diabetes: a prospective study.
Journal: Scientific reports
Published: January 02, 2023
A case of doxorubicin and cyclophosphamide therapy-induced type 1 diabetes: a case report.
Journal: Journal of medical case reports
Published: August 18, 2022
The Incidence and Risk Factors of Hyponatremia in Pulmonary Tuberculosis.
Journal: Journal of the Endocrine Society
Published: March 22, 2022
Comparison of Visceral Fat Reduction by Ipragliflozin and Metformin in Elderly Type 2 Diabetes Patients: Sub-Analysis of a Randomized-Controlled Study.
Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders
Published: September 08, 2020
Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME-V study).
Journal: Journal of diabetes investigation
Published: February 18, 2020
Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: A prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-V study).
Journal: Diabetes, obesity & metabolism
Published: January 11, 2019
Pituitary adenylate cyclase-activating polypeptide protects glomerular podocytes from inflammatory injuries.
Journal: Journal of diabetes research
Published: November 14, 2014
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with alpha-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on metformin or pioglitazone alone (Study for an Ultimate Combination Therapy to Control Diabetes with Sitagliptin-1): A multicenter, randomized, open-label, non-inferiority trial.
Journal: Journal of diabetes investigation
Published: June 06, 2014
Sitagliptin successfully ameliorates glycemic control in Werner syndrome with diabetes.
Journal: Diabetes care
Published: November 23, 2012
Last Updated: 09/26/2026